pharma · Aplastic Anemia · Advanced Hepatocellular Carcinoma
Kyowa Kirin International
KYOWA KIRIN AUSTRALIA PTY LTD
Kyowa Kirin International trial registry — 15 ClinicalTrials.gov studies with program phase, status, and indication context.
GB HQ
1995 Founded
690 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- GB
- Founded
- 1995
- Employees
- 690
- Programs
- 15
- Drugs
- 12
- Patents
- 0
Kyowa Kirin International clinical trials
Registry index of 15 ClinicalTrials.gov studies linked to Kyowa Kirin International programs — each row shows trial ID, program name, phase, status, and indication.
Kyowa Kirin International trial registry — 15 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Kyowa Kirin International.
-
2223-001 — Phase 1
Clinical update -
saxagliptin — Phase 2
Clinical update -
POTELIGEO 4 mg/mL concentrate for solution for infusion — Phase 2
Clinical update -
ARQ 197 — Phase 1
Clinical update -
KW-6500 — Phase 3
Clinical update -
KHK6640 — Phase 1
Clinical update -
KHK4827 — Phase 3
Clinical update -
OPC-262 — Phase 3
Clinical update
Trial registry
-
CTIS ↗ - 2024-515921-27-00CTIS ↗
POTELIGEO 4 mg/mL concentrate for solution for infusion
Mycosis fungoides/Sezary syndrome recurrent
- 2025-522523-96-00CTIS ↗
2223-001
T-cell Non-Hodgkin Lymphoma, Cutaneous T-cell lymphoma (CTCL), Peripheral T-cell lymphoma (PTCL)
-
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗